Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Oct 13;13:10373–10385. doi: 10.2147/OTT.S263728

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Ge et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

MiR-128 targets GOLM1. (A) The binding site between miR-28 and GOLM1 was predicted by TargetScan. (B) The luciferase activity of CC cells co-transfected with miR-128 mimic or NC mimic and luciferase reporters containing GOLM1 WT or GOLM1 MUT was determined by luciferase reporter gene assay. **P < 0.01 vs mimics NC group. (C) The protein level of GOLM1 was measured by Western blot assay. **P < 0.01 vs mimics NC group. (D) The expression of GOLM1 in CC and non-tumor tissues was measured by qRT-PCR. **P < 0.01 vs the non-tumor group. (E) The correlation between miR-128 and GOLM1. P < 0.001.